What Does the Stryker Rejuvinate and ABG II Hip Implant Settlement Mean?

Under the provisions of a new settlement, Stryker Corporation will provide a base payment of $300,000 to patients that received the Rejuvenate or ABG II hip systems and underwent revision surgery by November 3, 2014 to have the devices removed and replaced.

Moving forward the award may be adjusted based on certain factors including but not limited to things such multiple surgeries or infections and other medical complications that have stemmed as the result of a revision surgery.

Stryker Recall Background

Stryker first started selling the Rejuvenate hip system in 2009 and the ABG II hip system in 2010. The company recalled these hip devices two years later, in 2012, due to “fretting and/or corrosion at or about the modular-neck junction, which may result in adverse local tissue reaction, as well as possible pain and/or swelling, in or around your hip.”

Eligible patients have until March 2, 2015 to submit a claim for payment under the settlement.

Stryker Patients NOT Covered Under the Settlement

Patients that have one of these implants that fail or need revision surgery after the cut-off date of November 3, 201 will not be eligible for this phase of the settlement but do retain their rights for future claims for compensation against Stryker.

What Stryker Patients Should Do

Schedule an Appointment with your Surgeon.

If you received the Rejuvenate or ABG II Modular-Neck Hip Stem your surgeon will be able to evaluate how your hip implant is functioning and whether further testing is necessary.

In some cases, your surgeon may order blood tests or imaging to help evaluate your hip. You and your surgeon will determine the best care plan for you.

It is important that ALL patients who have received a Rejuvenate or ABG II modular-neck stem follow-up with their surgeon, even if they are not experiencing symptoms such as pain and/or swelling at or around their hip.

For more information, Stryker’s toll-free Patient Care Line can be reached by calling 1-888-317-0200 (U.S. and Canada only).